These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27380110)

  • 1. Emerging biomarkers in systemic sclerosis.
    Manetti M
    Curr Opin Rheumatol; 2016 Nov; 28(6):606-12. PubMed ID: 27380110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.
    Martyanov V; Whitfield ML
    Curr Opin Rheumatol; 2016 Jan; 28(1):83-8. PubMed ID: 26555452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers to guide clinical therapeutics in rheumatology?
    Robinson WH; Mao R
    Curr Opin Rheumatol; 2016 Mar; 28(2):168-75. PubMed ID: 26720904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.
    Wermuth PJ; Piera-Velazquez S; Jimenez SA
    Rheumatology (Oxford); 2018 Oct; 57(10):1698-1706. PubMed ID: 29140474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existing and novel biomarkers for precision medicine in systemic sclerosis.
    Wermuth PJ; Piera-Velazquez S; Rosenbloom J; Jimenez SA
    Nat Rev Rheumatol; 2018 Jul; 14(7):421-432. PubMed ID: 29789665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.
    Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
    Biomarkers; 2014 Aug; 19(5):345-55. PubMed ID: 24831309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in systemic sclerosis.
    Skaug B; Assassi S
    Curr Opin Rheumatol; 2019 Nov; 31(6):595-602. PubMed ID: 31436584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.
    Castelino FV; Varga J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
    Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
    Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Biomarkers in Systemic Sclerosis Disease.
    Zian Z; Bakkach J; Barakat A; Ghailani Nourouti N; Bennani Mechita M
    Biomed Res Int; 2018; 2018():3921247. PubMed ID: 29721505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic approach to understanding the pathogenesis of systemic sclerosis.
    Zuo X; Zhang L; Luo H; Li Y; Zhu H
    Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine in systemic sclerosis: facts and promises.
    Dobrota R; Mihai C; Distler O
    Curr Rheumatol Rep; 2014 Jun; 16(6):425. PubMed ID: 24752884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
    Vonk MC; Assassi S; Hoffmann-Vold AM
    Rheum Dis Clin North Am; 2023 May; 49(2):249-262. PubMed ID: 37028833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.
    Ligon C; Hummers LK
    Curr Rheumatol Rep; 2016 Mar; 18(3):17. PubMed ID: 26970773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-TproBNP as biomarker in systemic sclerosis.
    Schioppo T; Artusi C; Ciavarella T; Ingegnoli F; Murgo A; Zeni S; Chighizola C; Meroni PL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):292-301. PubMed ID: 22669751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020).
    Bălănescu P; Bălănescu A; Bălănescu E; Băicuş C
    Rom J Intern Med; 2021 Jun; 59(2):101-111. PubMed ID: 33565304
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic sclerosis: Recent insight in clinical management.
    Zanatta E; Codullo V; Avouac J; Allanore Y
    Joint Bone Spine; 2020 Jul; 87(4):293-299. PubMed ID: 31568838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the Role of the Active TGF-
    Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
    Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.